Ccm Investment Advisers LLC Abb Vie Inc. Transaction History

Ccm Investment Advisers LLC

  • $887 Million
  • Q3 2024

A detailed history of Ccm Investment Advisers LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ccm Investment Advisers LLC holds 80,873 shares of ABBV stock, worth $13.8 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
80,873
Previous 87,864 7.96%
Holding current value
$13.8 Million
Previous $15.1 Million 5.97%
% of portfolio
1.8%
Previous 1.78%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
SELL
$163.84 - $199.33 $1.15 Million - $1.39 Million
-6,991 Reduced 7.96%
80,873 $16 Million
Q2 2024

Jul 11, 2024
SELL
$154.79 - $180.76 $81,574 - $95,260
-527 Reduced 0.6%
87,864 $15.1 Million
Q1 2024

May 17, 2024
SELL
$159.82 - $182.1 $883,804 - $1.01 Million
-5,530 Reduced 5.89%
88,391 $16.1 Million
Q4 2023

Mar 05, 2024
SELL
$137.6 - $154.97 $8,256 - $9,298
-60 Reduced 0.06%
93,921 $14.6 Million
Q3 2023

Dec 08, 2023
BUY
$133.59 - $154.65 $76,413 - $88,459
572 Added 0.61%
93,981 $14 Million
Q2 2023

Aug 21, 2023
BUY
$132.51 - $164.9 $435,825 - $542,356
3,289 Added 3.65%
93,409 $12.6 Million
Q1 2023

May 17, 2023
BUY
$144.61 - $166.54 $672,147 - $774,077
4,648 Added 5.44%
90,120 $14.4 Million
Q4 2022

Feb 15, 2023
SELL
$138.31 - $165.87 $600,403 - $720,041
-4,341 Reduced 4.83%
85,472 $13.8 Million
Q3 2022

Nov 09, 2022
SELL
$134.21 - $153.93 $332,035 - $380,822
-2,474 Reduced 2.68%
89,813 $12.1 Million
Q2 2022

Jul 27, 2022
SELL
$137.62 - $174.96 $270,836 - $344,321
-1,968 Reduced 2.09%
92,287 $14.1 Million
Q1 2022

May 03, 2022
SELL
$131.98 - $163.75 $994,601 - $1.23 Million
-7,536 Reduced 7.4%
94,255 $15.3 Million
Q4 2021

Feb 01, 2022
BUY
$107.43 - $135.93 $185,746 - $235,022
1,729 Added 1.73%
101,791 $13.8 Million
Q3 2021

Oct 26, 2021
BUY
$106.4 - $120.78 $255,147 - $289,630
2,398 Added 2.46%
100,062 $10.8 Million
Q2 2021

Jul 30, 2021
BUY
$105.21 - $117.21 $1.08 Million - $1.21 Million
10,286 Added 11.77%
97,664 $11 Million
Q1 2021

May 07, 2021
BUY
$102.3 - $112.62 $157,030 - $172,871
1,535 Added 1.79%
87,378 $9.46 Million
Q4 2020

Feb 25, 2021
BUY
$80.49 - $108.67 $870,418 - $1.18 Million
10,814 Added 14.41%
85,843 $9.2 Million
Q3 2020

Nov 10, 2020
BUY
$85.91 - $100.83 $6.45 Million - $7.57 Million
75,029 New
75,029 $6.57 Million
Q1 2020

May 22, 2020
SELL
$64.5 - $97.79 $171,376 - $259,828
-2,657 Closed
0 $0
Q4 2019

Feb 20, 2020
SELL
$72.13 - $90.25 $12,622 - $15,793
-175 Reduced 6.18%
2,657 $235,000
Q3 2019

Nov 19, 2019
SELL
$62.98 - $75.72 $59,201 - $71,176
-940 Reduced 24.92%
2,832 $214,000
Q2 2019

Aug 05, 2019
SELL
$65.7 - $83.98 $426,721 - $545,450
-6,495 Reduced 63.26%
3,772 $274,000
Q1 2019

May 02, 2019
SELL
$77.14 - $90.79 $839,823 - $988,430
-10,887 Reduced 51.47%
10,267 $827,000
Q4 2018

Feb 12, 2019
SELL
$77.85 - $96.01 $828,713 - $1.02 Million
-10,645 Reduced 33.48%
21,154 $1.95 Million
Q3 2018

Nov 05, 2018
SELL
$88.91 - $98.84 $4.03 Million - $4.48 Million
-45,288 Reduced 58.75%
31,799 $3.01 Million
Q2 2018

Aug 13, 2018
SELL
$89.78 - $106.23 $4.21 Million - $4.98 Million
-46,865 Reduced 37.81%
77,087 $7.14 Million
Q1 2018

May 09, 2018
SELL
$92.01 - $123.21 $328,291 - $439,613
-3,568 Reduced 2.8%
123,952 $11.7 Million
Q4 2017

Feb 22, 2018
SELL
$89.56 - $98.21 $602,380 - $660,560
-6,726 Reduced 5.01%
127,520 $12.3 Million
Q3 2017

Nov 02, 2017
BUY
$69.85 - $89.22 $9.38 Million - $12 Million
134,246
134,246 $11.9 Million

Others Institutions Holding ABBV

# of Institutions
3,817
Shares Held
1.25B
Call Options Held
13M
Put Options Held
10M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ccm Investment Advisers LLC Portfolio

Follow Ccm Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email